Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Dunn

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Annals of Internal Medicine|April 20, 2011
ACP Journal Club. Apixaban reduced stroke and systemic embolism compared with aspirin in adults with AF for whom VKA therapy was unsuitableAndrew Dunn
Evidence-Based Medicine|January 11, 2007
Review: wearing graduated compression stockings during air travel reduces the risk of deep venous thromboembolismAndrew Dunn
ACP Journal Club|July 4, 2006
Risks for myocardial infarction or nonstroke vascular death after ischemic stroke or transient ischemic attack were each 2% per yearAndrew Dunn
ACP Journal Club|July 4, 2006
The revised Geneva score predicted pulmonary embolism in patients with shortness of breath or chest painAndrew Dunn
ACP Journal Club|July 1, 2008
CT pulmonary angiography was not inferior to ventilation-perfusion lung scanning for ruling out pulmonary embolismAndrew Dunn
Annals of Internal Medicine|June 21, 2017
In VTE, extending anticoagulation with rivaroxaban vs aspirin reduced recurrence without increasing bleedingAndrew Dunn
The Mount Sinai Journal of Medicine, New York|October 2, 2008
Hospital medicine in high-def: importance of defining mission of hospitalist groupsAndrew Dunn
Annals of Internal Medicine|March 19, 2014
In AF or VTE, acenocoumarol or phenprocoumon dosing by genotype did not affect time in therapeutic rangeAndrew Dunn
Annals of Internal Medicine|March 19, 2014
In AF or VTE, warfarin dosing by genotype improved time in therapeutic range but not clinical outcomesAndrew Dunn
Annals of Internal Medicine|October 21, 2014
A 4-marker model predicted a complicated course in normotensive patients with acute symptomatic PEAndrew Dunn
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Annals of Internal Medicine|April 20, 2011
ACP Journal Club. Apixaban reduced stroke and systemic embolism compared with aspirin in adults with AF for whom VKA therapy was unsuitableAndrew Dunn
Evidence-Based Medicine|January 11, 2007
Review: wearing graduated compression stockings during air travel reduces the risk of deep venous thromboembolismAndrew Dunn
ACP Journal Club|July 4, 2006
Risks for myocardial infarction or nonstroke vascular death after ischemic stroke or transient ischemic attack were each 2% per yearAndrew Dunn
ACP Journal Club|July 4, 2006
The revised Geneva score predicted pulmonary embolism in patients with shortness of breath or chest painAndrew Dunn
ACP Journal Club|July 1, 2008
CT pulmonary angiography was not inferior to ventilation-perfusion lung scanning for ruling out pulmonary embolismAndrew Dunn
Annals of Internal Medicine|June 21, 2017
In VTE, extending anticoagulation with rivaroxaban vs aspirin reduced recurrence without increasing bleedingAndrew Dunn
The Mount Sinai Journal of Medicine, New York|October 2, 2008
Hospital medicine in high-def: importance of defining mission of hospitalist groupsAndrew Dunn
Annals of Internal Medicine|March 19, 2014
In AF or VTE, acenocoumarol or phenprocoumon dosing by genotype did not affect time in therapeutic rangeAndrew Dunn
Annals of Internal Medicine|March 19, 2014
In AF or VTE, warfarin dosing by genotype improved time in therapeutic range but not clinical outcomesAndrew Dunn
Annals of Internal Medicine|October 21, 2014
A 4-marker model predicted a complicated course in normotensive patients with acute symptomatic PEAndrew Dunn
Pageof 11